ANDREASSI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 125
AS - Asia 109
EU - Europa 60
SA - Sud America 15
AF - Africa 3
Totale 312
Nazione #
US - Stati Uniti d'America 120
SG - Singapore 61
IT - Italia 19
CN - Cina 14
BR - Brasile 13
VN - Vietnam 12
RU - Federazione Russa 10
DE - Germania 7
HK - Hong Kong 7
GB - Regno Unito 6
BD - Bangladesh 4
CA - Canada 3
FI - Finlandia 3
IE - Irlanda 3
JP - Giappone 3
MY - Malesia 3
ES - Italia 2
FR - Francia 2
MX - Messico 2
NL - Olanda 2
AO - Angola 1
AR - Argentina 1
AZ - Azerbaigian 1
BE - Belgio 1
BN - Brunei Darussalam 1
BW - Botswana 1
DZ - Algeria 1
HU - Ungheria 1
ID - Indonesia 1
IR - Iran 1
LT - Lituania 1
PL - Polonia 1
SE - Svezia 1
TW - Taiwan 1
UA - Ucraina 1
VE - Venezuela 1
Totale 312
Città #
Singapore 45
Ashburn 14
San Jose 13
Santa Clara 8
Chandler 7
Ho Chi Minh City 7
Hong Kong 7
Beijing 6
Council Bluffs 6
New York 6
Rome 5
São Paulo 5
Chicago 3
Dublin 3
Hanoi 3
Munich 3
Nuremberg 3
Orem 3
Tokyo 3
Ann Arbor 2
Buffalo 2
Creede 2
Guangzhou 2
Kuala Lumpur 2
Los Angeles 2
Manchester 2
Medford 2
Mexico City 2
Milan 2
Montreal 2
North Bergen 2
The Dalles 2
Algiers 1
Amsterdam 1
Annapolis 1
Atlanta 1
Baku 1
Bandar Seri Begawan 1
Barra Bonita 1
Bauru 1
Berlin 1
Boston 1
Brussels 1
Budapest 1
Bắc Giang 1
Cambridge 1
Candeias 1
Caracas 1
Cardiff 1
Cardito 1
Carini 1
Columbia 1
Covina 1
Denver 1
Elk Grove Village 1
Fairfield 1
Fortaleza 1
Gaborone 1
Helsinki 1
Henrico 1
Houston 1
Itaperuna 1
Jakarta 1
Kajang 1
Kilburn 1
La Banda 1
Lappeenranta 1
Las Vegas 1
Lauterbourg 1
Lawrence 1
Lobito 1
Macaé 1
Poplar 1
Porcia 1
Roubaix 1
Salt Lake City 1
San Francisco 1
Sassari 1
Stockholm 1
São Raimundo Nonato 1
Tehran 1
Thái Bình 1
Toronto 1
Turku 1
Urussanga 1
Vilnius 1
Warsaw 1
Totale 231
Nome #
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation 124
Update of Respiratory Viruses Infection Rate in the Pandemic SARS-CoV-2 Period in Symptomatic Patients (December 2021-April 2023) 111
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 94
Totale 329
Categoria #
all - tutte 1.418
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.418


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 10 1 0 4 1 0 4
2022/202319 1 2 0 2 1 5 6 0 1 0 1 0
2023/20246 0 0 1 0 0 0 1 0 0 3 0 1
2024/2025106 2 28 22 6 5 9 10 0 6 6 6 6
2025/2026178 12 6 17 25 26 7 21 17 17 16 6 8
Totale 329